Carboplatin, a cisplatin analog, is a platinum-based antineoplastic chemotherapeutic agent that has been used in cancer research including in vitro studies on lung, neck, breast, and cervical cancers. It was co-developed by Bristol Myers Squibb and the Institute of Cancer Research. Cisplatin reacts with silver nitrate and then cyclobutane-1,2-dicarboxylic acid to form carboplatin.
Carboplatin is very slightly soluble in acetone and alcohol but sparingly soluble in water.